Bellevue Asset Management AG quarter change: USA Stocks, Reduced
In share positions in stocks (listed in the US), from the quarter ended 2015-09-30 to 2015-12-31, Bellevue Asset Management AG opened 4 positions, added to 25, reduced 12, sold out of 1 and left 27 unchanged. The largest increase in value was CAH (+$9,162,000); the largest decrease was THC (-$4,368,000).
- THC: Country of operation United States; Class COM NEW; Shares 2015-09-30 126,510; Shares 2015-12-31 10,000.
- REGN: Country of operation United States; Class COM; Shares 2015-09-30 38,900; Shares 2015-12-31 36,400.
- ABT: Country of operation United States; Class COM; Shares 2015-09-30 463,000; Shares 2015-12-31 381,500.
- LGND: Country of operation United States; Class COM NEW; Shares 2015-09-30 95,730; Shares 2015-12-31 81,640.
Two Form 13F-HR filings compared (SEC CIK 1642343): 2015-09-30 (filed 2015-11-12) and 2015-12-31 (filed 2016-02-12). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
| Stock | Country of operation | Class | Shares 2015-09-30 | Shares 2015-12-31 | Share change | Value 2015-09-30 | Value 2015-12-31 | Value change |
|---|---|---|---|---|---|---|---|---|
| THC Tenet Healthcare Corporation | United States | COM NEW | 126,510 | 10,000 | -116,510 | $4,671,000 | $303,000 | -$4,368,000 |
| REGN Regeneron Pharmaceuticals, Inc. | United States | COM | 38,900 | 36,400 | -2,500 | $18,094,000 | $19,760,000 | +$1,666,000 |
| ABT Abbott Laboratories | United States | COM | 463,000 | 381,500 | -81,500 | $18,622,000 | $17,133,000 | -$1,489,000 |
| LGND Ligand Pharmaceuticals Incorporated | United States | COM NEW | 95,730 | 81,640 | -14,090 | $8,199,000 | $8,851,000 | +$652,000 |
| GILD Gilead Sciences, Inc. | United States | COM | 254,050 | 240,120 | -13,930 | $24,945,000 | $24,298,000 | -$647,000 |
| MYGN Myriad Genetics, Inc. | United States | COM | 33,000 | 14,000 | -19,000 | $1,237,000 | $604,000 | -$633,000 |
| ABBV Abbvie Inc. | United States | COM | 27,000 | 15,000 | -12,000 | $1,469,000 | $889,000 | -$580,000 |
| ACAD Acadia Pharmaceuticals, Inc. | United States | COM | 59,000 | 45,000 | -14,000 | $1,951,000 | $1,604,000 | -$347,000 |
| ALNY Alnylam Pharmaceuticals Inc. | United States | COM | 32,000 | 24,000 | -8,000 | $2,572,000 | $2,259,000 | -$313,000 |
| PODD Insulet Corporation | United States | COM | 22,500 | 21,000 | -1,500 | $583,000 | $794,000 | +$211,000 |
| VRTX Vertex Pharmaceuticals Incorporated | United States | COM | 82,500 | 67,000 | -15,500 | $8,592,000 | $8,431,000 | -$161,000 |
| ISRG Intuitive Surgical, Inc. | United States | COM NEW | 13,550 | 11,550 | -2,000 | $6,227,000 | $6,308,000 | +$81,000 |
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Not available yet | |||